Bengaluru: GSK said on Monday it will receive up to USD 690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to linerixibat, an experimental treatment for severe itching…
Frankfurt: Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising breast cancer drug candidate giredestrant can help newly diagnosed patients.At 0956…
Bengaluru: The U.S. Food and Drug Administration plans to ease testing requirements for companies developing biosimilar drugs, Bloomberg News reported, citing an agency official and internal documents.The FDA is expected…
A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.
The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.
A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated glomerular filtration rates (eGFR) value at least 30% lower than their…
Researchers have found in a new study that the hemoglobin, albumin, lymphocyte, and platelet score serves as an independent predictor of 30-day readmission in patients with acute exacerbation of chronic…
University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental “living eye drop” that uses naturally occurring eye bacteria to support corneal wound healing. The proof-of‑concept study, published…
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.
Women with metastatic breast cancer often face multiple chronic conditions, and high blood pressure is among the most common. Nearly half of women in this study population had hypertension at…